Shandong Sino-Agri United Biotechnology Co., Ltd. Class A
003042.SZ · SHZ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 1.93B | 361.73M | 71.69M | 73.14M | 0.51 |
| 2023 FY | 1.68B | 81.95M | -237.24M | -192.47M | -1.35 |
| 2024 FY | 2.01B | 159.99M | -135.61M | -122.45M | -0.86 |
| 2025 FY | 1.86B | 175.64M | -127.01M | -136.61M | -0.96 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 3.54B | 1.86B | 315.81M | 570.95M | 1.68B |
| 2023 FY | 3.74B | 2.27B | 571.58M | 800.39M | 1.47B |
| 2024 FY | 3.93B | 2.58B | 425.23M | 928.44M | 1.35B |
| 2025 FY | 3.82B | 2.60B | 169.01M | 1.60B | 1.22B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | -40.39M | -129.15M | -169.54M | -21.92M | -259.51M |
| 2023 FY | 86.90M | -134.93M | -48.03M | -35.24M | 231.57M |
| 2024 FY | 104.90M | -174.70M | -69.81M | -25.13M | -138.58M |
| 2025 FY | 15.37M | -129.50M | -114.13M | -20.16M | -256.22M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2023 FY | 2.72B | 2.95B | — | — | — |
| 2024 FY | 2.03B | 2.53B | — | — | — |
| 2025 FY | 2.29B | 3.72B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 544.23M | 65.12M | -567.47K | -849.26K | 0.00 |
| 2025 Q3 | 443.98M | 44.83M | -55.89M | -48.00M | -0.43 |
| 2025 Q4 | 352.88M | 14.10M | -103.20M | -91.81M | -0.64 |
| 2026 Q1 | 642.95M | 83.78M | 19.22M | 2.00M | 0.01 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 4.09B | 2.73B | 305.80M | 1.06B | 1.36B |
| 2025 Q3 | 3.91B | 2.59B | 236.78M | 1.66B | 1.31B |
| 2025 Q4 | 3.82B | 2.60B | 169.01M | 1.60B | 1.22B |
| 2026 Q1 | 3.93B | 2.71B | 229.58M | 1.73B | 1.22B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 9.93M | -4.87M | 5.05M | -5.44M | -34.71K |
| 2025 Q3 | -42.18M | -5.29M | -47.47M | — | -69.02M |
| 2025 Q4 | 105.32M | -117.63M | -12.31M | -4.30M | -67.78M |
| 2026 Q1 | -99.22M | -8.10M | -107.32M | -4.97M | 60.58M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 3.10B | 3.86B | — | — | — |
| 2025 Q3 | 1.81B | 3.23B | — | — | — |
| 2025 Q4 | 2.29B | 3.72B | — | — | — |
| 2026 Q1 | 2.65B | 4.15B | — | — | — |